This Pharma Is Starting to Recover Nicely

Like so many biopharma stocks, Aurinia Pharmaceuticals (AUPH)  was in need of care over much of 2022. But things are now looking better for the company and the shares have started to rebound. The stoc...

Blackstone Stock Is a Good Investment, Even in a Downbeat Economy

These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or rec...